Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years.
Charles-Schoeman C, Giles JT, Lane NE, Choy E, Furst DE, Vencovský J, Wilson AG, Burmester GR, Coombs D, Penn SK, Khan N, Yee JB, Rahawi K, McInnes IB.
Charles-Schoeman C, et al. Among authors: wilson ag.
Rheumatol Ther. 2024 Feb;11(1):157-175. doi: 10.1007/s40744-023-00624-3. Epub 2024 Jan 5.
Rheumatol Ther. 2024.
PMID: 38180720
Free PMC article.